hexokinase reaction, and there was a direct correlation between the Ki for a particular derivative and its ability to act as an affinity matrix when immobilized to CNBr-activated Sepharose 4B. Muscle hexokinase type II could be chromatographed on the Sepharose conjugates of all four N-aminoacylglucosamine derivatives, although the N-aminohexanoylglucosamine derivative proved best. This same derivative was readily able to bind hepatic glucokinase and hexokinase type III, but Sepharose-N-amino-octanoylglucosamine was better for these enzymes and was the only derivative capable of binding kidney hexokinase type I efficiently. Separate studies with yeast hexokinase showed that again only the Sepharose-N-amino-octanoylglucosamine was capable of acting as an efficient affinity matrix for this enzyme. Implications of these studies in our understanding of affinity-chromatography operation are discussed.
Lack of efficient purification procedures for the mammalian hexokinases (ATP-D-hexose 6-phosphotransferases, EC 2.7.1.1) has hindered any in-depth investigations into their physiological control and mode of action. Until recently the only isoenzyme to be purified to homogeneity was type I from brain (Schwartz & Basford, 1967; Chou & Wilson, 1972) and pig heart (Easterby & O'Brien, 1973) . The selective extraction of the mitochondria to which this isoenzyme is bound simplified the purification process, but the other three isoenzymes could not be obtained so easily. However, and Holroyde et al. (1976a,b) succeeded in purifying hepatic glucokinase (hexokinase type IV, as it is well known that N-acetylglucosamine is a good competitive inhibitor of all four isoenzymes (Walker, 1966) . It was eventually found, however, that, by adjusting the operating conditions slightly, hexokinase type II from rat muscle could be purified to homogeneity . This prompted a more thorough investigation of the reactions between the hexokinases and this affinity matrix. Various glucosamine compounds were synthesized, giving a series of derivatives in which the length of the carbon chain attached to the amino group was varied. This had the effect of altering the length of the spacer arm attaching the glucosamine to the Sepharose When the inhibition with respect to glucose of rat and yeast hexokinase isoenzymes by these compounds was investigated, a definite correlation was found to exist between the K, of a compound in free solution and its effectiveness as an affinity matrix when immobilized to Sepharose. Thus, by varying either the length of the aminoacyl spacer molecule and/or the concentration of ligand attached to the gel, it has been possible to prepare a glucosamine affinity matrix capable of purifying each of the hexokinase isoenzymes to homogeneity on a large scale. Some of this work has been reported in preliminary form (Wright et al., 1976) .
Materials and Methods Chemicals
Coenzymes, Dowex ion-exchange resins and dithiothreitol were purchased from Sigma (London) Chemical Co., Kingston-upon-Thames, Surrey, U.K. 
Hexokinase preparations
Rat hepatic glucokinase was prepared as described by Holroyde et al. (1976b) and rat skeletal-muscle hexokinase type II as described by . Hexokinase types I and III were prepared from kidney and liver respectively. The initial stages of the preparation are described below and are based on our method of preparation of hepatic glucokinase and muscle hexokinase type II. Essentially the enzymes are extracted from the tissues, adsorbed batchwise on DEAE-cellulose and then chromatographed on either DEAE-Sephadex (hexokinase type III) or hydroxyapatite (hexokinase type I) before their final purification on the affinity columns described in the Results section.
Preparation of rat kidney hexokinase type I Frozen rat kidneys (400g) (purchased from Olac (Northern), Bicester, Oxon., U.K.) were chopped finely with scissors and homogenized in 2vol. of 20mM-triethanolamine/HCl, pH7.0, containing 0.2M-MgCl2, 10mM-KCl, 50mM-glucose, 1mM-EDTA, 0.5 mM-dithiothreitol and 5 % (v/v) glycerol in an Ato-Mix blender for 2 min. The homogenate was kept for 45 min at 4°C before centrifuging at 23 5OOg for 45min. The supernatant was adjusted to pH8 by the slow addition of 2M-triethanolamine and then dialysed against several changes of the above buffer (at pH8 and with the MgCl2 omitted) until the conductivity of the non-diffusible material was approx. 2mQ'-. The (Fig. 5) .
Preparation of rat hepatic hexokinase type III The 50 rats were starved for 24h and then fed with carbon tetrachloride (20%, v/v) in liquid paraffin (0.5ml/lOOg body wt.) as described by Ueda et al. (1975) . (This treatment destroys the hepatic glucokinase and enhances the low-Km hexokinase activity.) The rats were killed after an additional 48 h without food, and their livers were removed and homogenized in 2vol. of 10mM-potassium phosphate buffer, pH7.0, containing 10mM-glucose, 5mM-EDTA, 0.5mM-dithiothreitol and 10% (v/v) glycerol for 2min in an Ato-Mix blender. After centrifugation (23 5OOg for 1 h), the supernatant was adsorbed on DEAE-cellulose (about lOg of moist gel/lOOml of supernatant) equilibrated with the extraction buffer, and the DEAE-cellulose was then collected on a Buchner funnel. It was washed wvith the above buffer containing 0.1 M-KCI (1 litre) under suction and then packed into a column (20cm x 4.5cm), and the washing was continued until the A280 of the emerging fractions fell below 0.2. Hexokinase activity was step-eluted by raising the KCl concentration in this buffer to 0.4M. The active fractions were pooled and dialysed against two changes of 1.5 litres each of 50mM-potassium phosphate buffer, pH7.0, containing 10mM-glucose, 1 mM-EDTA, 1 mM-MgCl2, 0.5 mM-dithiothreitol and 10% glycerol (v/v) for about 3 h until the conductivity of the non-diffusible material was down to 5 mQ.-'. This material was then applied to a DEAE-Sephadex column (20cm x 4.5 cm) equilibrated with the above buffer but containing 0.1M-potassium phosphate, pH7.0. The column was washed further with this buffer until the A280 fell to 0.2 and was then eluted with a linear gradient to 0.5 M-potassium phosphate, pH 7.0, containing the above ingredients, over 2 litres. Some hexokinase activity appeared in the washings before application of the gradient and was shown to be hexokinase type II by electrophoresis (see below). This was occasionally saved and treated as described in the Results section ( Fig. 6 ) should this isoenzyme be Vol. 175 required. The hexokinase activity eluted under the gradient contained both type II and type III isoenzymes, which could be most easily resolved by affinity chromatography (Fig. 6 ). The type III enzyme was not very stable at this stage of the preparation and the affinity-chromatography step was performed immediately. At this stage, the hexokinase activity was about 40% of that in the original liver extract. (Some of the 'loss' was hexokinase type I, which does not adsorb on the DEAEcellulose at pH 7.0, and type II, some of which is lost at each ion-exchange step, although there is still a certain amount in the preparation at this stage.) The specific activity was 12.1 units/mg, which represents a 2500-fold purification.
The kinetic experiments described in the early part of the Results section were performed with homogeneous samples of rat hepatic glucokinase, rat skeletal-muscle hexokinase type II and yeast hexokinase and with samples of hexokinase types I and III after the two preliminary purification steps described above. Rat kidney hexokinase type I is pure with respect to hexokinase type at this stage, but hepatic hexokinase type III was obtained by pooling fractions from the higher-ionic-strength side of the peak eluted from the DEAE-Sephadex column and checking for type-homogeneity by electrophoresis in 0.5 % agarose (see below).
Assay of hexokinase activity
Hexokinase activity was measured at 300C in a total volume of 0.75 ml by the coupled assay method of Parry & Walker (1966) as described by Storer & Cornish-Bowden (1974) . Glucokinase was assayed routinely at a glucose concentration of 100mM, and the low-Km hexokinases were assayed at either 0.5mM-glucose or 0.1 mM-glucose (type III). For the inhibition studies glucose was removed from the enzyme solutions by passage down a Sephadex G-25 column [usually a 1 ml sample applied to a 20cm x 1 cm column operated in 20mM-triethanolamine/HCI, pH7.0, containing 0.2M-KCI, 0.5mM-dithiothreitol, lmM-EDTA, 1mM-MgCl2 and 5% (v/v) glycerol] and the enzyme used straight away.
Glucose was removed from the glucose 6-phosphate dehydrogenase by overnight dialysis against 20mM-Tris/HCl buffer, pH7.5. The competitive inhibition constants (Ki values) were determined by the method of Dixon (1953) and the uncompetitive component (K') by the method of Cornish-Bowden (1974 , 1976 .
One unit of hexokinase activity is defined as that which catalyses the formation of 1,umol of glucose 6-phosphate/min at 30°C. Preparation ofglucosamine derivatives
An amide linkage was synthesized between the amino group of glucosamine and the carboxy group of the following amino acids: 3-aminopropionic acid, 4-aminobutyric acid, 6-aminohexanoic acid and 8-amino-octanoic acid (Holroyde et al., 1976a) . The final products were not crystallized, but gave single spots on high-voltage paper electrophoresis at pH6.5 (mobilities relative to glucosamine: glucosamine, 1.0; products, 0.81-0.87) and on ascending paper chromatography in two solvent systems (Holroyde et al., 1976a) . Positive reactions were obtained with both ninhydrin and AgNO3 (Holroyde et al., 1976a) . After acid hydrolysis (6M-HCl, 20h at 105°C) chromatographic analysis on an amino acid analyser showed only the appropriate amino acid and glucosamine in a molar ratio of 1:1. The structures shown in Fig. 1 were therefore assigned to the products.
Preparation of Sepharose adsorbents
The ligands were attached to CNBr-activated Sepharose 4B under the conditions described by Trayer et al. (1974) . The ligands were coupled at a concentration of 10-12,umol/g of gel and characterized as described by Holroyde et al. (1976a) . The gels were diluted to the required ligand concentration by dilution with unsubstituted Sepharose 4B (Holroyde et al., 1976a) . The adsorbents are designated as e.g., Sepharose-C3-GlcN for glucosamine linked to Sepharose by a C3 spacer.
Electrophoretic methods
Enzyme purity and estimations of molecular weight were determined by polyacrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate (Weber & Osborn, 1969) . To identify isoenzymes in the early part of this work, electrophoresis was carried out in the absence of sodium dodecyl sulphate in polyacrylamide gels and the gels were stained for enzymic activity (Grossman & Potter, 1974) , but most frequently electrophoresis in 0.5% agarose was used (Allen & Walker, 1976) . The latter procedure gave greatly improved separation.
Analytical methods
Conductivity measurements were made on a Radiometer type CDM conductivity meter (Radiometer, Copenhagen, Denmark). Protein determinations were made by the turbidimetric tannin micro method of Mejbaum-Katzenellenbogen & Dobryszycka (1959) , with bovine serum albumin as standard. Amino acid analyses were performed with a Beckman model 120B amino acid analyser, with correction for losses as described by Holroyde et al. (1976a) .
Results
Inhibitory properties of the N-aminoacylglucosamine derivatives
The general structure of the four glucosamine derivatives synthesized is shown in Fig. 1 
pyranose (C6-GlcN), and n = 7, N-(8-aminooctanoyl) -2 -amino -2 -deoxy -D -glucopyranose (C8 -GlcN)] is described in the Materials and Methods section.
competitive inhibition constant (K1) of each isoenzyme for each ligand was determined first with impure enzyme fractions [but still homogeneous with respect to hexokinase type as judged by electrophoresis (see the Materials and Methods section)] and later, as the findings were extended, the experiments were repeated with pure isoenzymes. All the results were in good agreement, and in separate assays for ADP production (Storer & CornishBowden, 1977 ) the glucosamine derivatives could not be shown to be substrates. Typical inhibition plots are shown in Fig. 2 , where the Ki in free solution of hepatic hexokinase type III for the C3-GlcN derivative is shown to be 5.9mM. The inhibition is purely competitive, as indicated by Fig. 2(b The results of the determinations of competitive inhibition constant (KI) obtained from the plot of 1/v against [I] for all the enzymes are shown in Fig. 3 plotted against the number of carbon atoms in the aminoacyl chain of the glucosamine derivative. Results for N-acetylglucosamine, which is generally a better inhibitor of all the isoenzymes than the amino- acyl derivatives, are shown for comparison. The introduction of an additional aminomethyl moiety to the N-acetylglucosamine side chain (i.e. the C3-GlcN derivative) considerably lessens its effectiveness as an inhibitor, but, as the number of carbon atoms in the chains was increased, so was the effectiveness of the various ligands as free solution inhibitors.
Small-scale affinity-chromatography experiments A direct correlation was found to exist between the K1 of a particular derivative and its ability to act as an affinity matrix when immobilized on Sepharose. In a series of small-scale experiments, some of which are illustrated in Fig. 4 , it became apparent that, provided Vol. 175 The K1 values, estimated by plotting 1/v against inhibitor concentration as described in Fig. 2 , are plotted against the number of C atoms in the Naminoacyl side chain of the glucosamine derivatives depicted in Fig. 1. (Number of C atoms = n + 1 in Fig. 1.) (Fig. 5) . If the C6-GIcN derivative was attached to Sepharose at very high ligand concentrations (12,umol/g of Sepharose) the hexokinase type I (Ki 2.75mM) was partially retained on the column, but not sufficiently well to allow this to be used in a purification scheme. At lower ligand concentrations (Fig. 4b ) the isoenzyme passes through unretarded. Similarly muscle hexokinase type II will bind efficiently to any of the immobilized glucosamine derivatives, but liver Fraction no. Fig. 4 . Chromatography of the mammalian hexokinase isoenzymes on various Sepharose-N-aminoacylglucosamine derivatives All columns were the same dimensions (10cm x 0.8cm) and were operated in 20mM-triethanolamine/HCI, pH7.0, containing l0mM-KCI, 4mM-EDTA, 7.5mm-MgCl2, I mM-dithiothreitol and 5%/ (v/v) glycerol at 20ml/h, and 2ml fractions were collected. Hexokinase (activity 2 units in 2-3 ml) was applied to each column. At the arrow, 0.5 M-glucose was included in the developing buffer. (Fig. 4c) .
It should be emphasized that attachment of either glucosamine (Chesher et al., 1973) or any of the various amino acids (or their aminoalkane analogues) directly to CNBr-activated Sepharose did not provide matrices that showed any significant interaction with 1978 the isoenzymes. Nor did the amino acids and the aminoalkanes inhibit the hexokinase activities in free solution.
The importance of choosing the most effective ligand concentration attached to the gel (and how to adjust this) when designing a large-scale affinitymatrix operation has been reported earlier (Holroyde et al., 1976a,b; Trayer et al., 1978; Trayer, 1978; Harvey etal., 1974) . Furthermore, better purifications of these isoenzymes are obtained if a ligand concentration is chosen so that the enzyme is bound sufficiently tightly to allow the column to be thoroughly washed with as high a KCI concentration as possible, which, in addition to removing further unwanted protein, 'loosens' the enzyme-immobilized ligand interaction. Elution of the required enzyme can then be effected specifically in a small volume by including glucose in the developing buffer.
Large-scale preparation of hexokinase types I and III
The large-scale purifications of hexokinase type I from rat kidney (Fig. 5 ) and hepatic hexokinase type III (Fig. 6) were both carried out on a Sepharose-C8-GlcN affinity matrix; neither enzyme had been previously purified to homogeneity. After prior chromatography of the kidney extracts on DEAEcellulose and hydroxyapatite (see the Materials and Methods section), the fractions containing hexokinase type I were applied to a Sepharose-C8-GIcN column; which was operated as described in Fig. 5 . Washing of the column with 70mM-KCl removed -unwanted protein, and the enzyme was specifically eluted by inclusion of 200mM-glucose in the developing buffer. At this stage the hexokinase fraction gave one major and one minor band on polyacrylamide-gel electrophoresis in sodium dodecyl sulphate. A further passage down the affinity column removed the minor contaminant, leaving a band migrating in a position equivalent to-a mol.wt. of 96000. Identical molecular weights have been recorded for hexokinase type I from heart (Easterby & O'Brien, 1973; Easterby, 1975 ) and brain (Chou & Wilson, 1972; Chakrabarti & Kenkare, 1974) . The firnal product had a specific activity of about 180 units/mg, which represented a 21 500-fold purification. The two affinity-chromatography steps were performed in greater than 85% yield. Fraction no. Fig. 5 . Purification of rat kidney hexokinase type I on Sepharose-C8-GlcN The extracts of 400g of rat kidneys were partially purified as described in the Materials and Methods section. The sample was dialysed against 20mM-triethanolamine/HCl, pH 7.0, containing lOmM-KCI, 4mM-EDTA, 0.5 mM-dithiothreitol and 5% (v/v) glycerol and applied directly to the affinity column (25cm x 3 cm, adjusted to 5,umol of ligand per g wet wt. of packed gel as described under 'Preparation of Sepharose adsorbents') equilibrated in the same buffer, The column w4s operated at 40ml/h, and 6ml fractions were collected. At arrow A the KC1 concentration in the buffer was increased to 70mM, and at arrow B 200mM-glucose was also included. e, A280; o, hexokinase activity. The extracts of the livers of 50 carbon tetrachloride-treated rats were partially purified by ion-exchange chromatography as described in the Materials and Methods section. The sample, containing only hexokinase types II and III activities, was dialysed against the buffer described in Fig. 6 and applied directly to the affinity column (20cm x 3 cm, adjusted to 3.85,pmol of ligand/g of gel as described under 'Preparation of Sepharose adsorbents') equilibrated to this buffer. The column was washed with this buffer until the A280 of the emerging solution was * 0.1 (not shown).
At arrow A the KCl concentration of the buffer was increased to 140mM, and at arrow B 50mM-glucose was added to this. The column was operated at 40ml/h, and 4ml fractions were collected. e, A280; o, hexokinase activity. Electrophoretic analysis (Allen & Walker, 1976) indicated that the protein eluted by the 140mM-KCI alone contained only the hexokinase type II isoenzyme together with other protein material, whereas the KCI/glucose eluate contained homogeneous hexokinase type III.
Hepatic hexokinase type III could have been purified to homogeneity on either the C6-GlcN or the C8-GIcN derivatives attached to Sepharose; the C8-GlcN derivative was chosen since hexokinase type II is a major contaminant after the two ion-exchange steps (see the Materials and Methods section) and this glucosamine derivative best distinguishes between them (see Fig. 3 ). Fig. 6 shows the results of applying the partially purified hexokinase type III preparation to Sepharose-C8-GlcN (3.85pmol of ligand/g of gel). After washing of the column with the application buffer (containing lOmM-KCI) ( . The enzyme would bind in this buffer and could be subsequently eluted by glucose.
Hexokinase type III was found to be very unstable in our hands even on the addition to the buffers of glucose, dithiothreitol and glycerol, ingredients that help stabilize glucokinase (Holroyde et al., 1976b) . The freshly eluted enzyme had a specific activity of about 200 units/mg and gave a single migrating species on polyacrylamide gels in the presence of sodium dodecyl sulphate (mol.wt. 98000). The preparation appeared to contain trace amounts of proteinases, since the band migrating at a position equivalent to a mol.wt. of 98000 gradually disappeared on standing over a 2-3-week period to be replaced by faster-migrating bands with a concomitant loss of enzymic activity. We The usefulness of the kinetic data in helping to predict affinity-chromatography behaviour was very obvious in our studies on yeast hexokinase. Our early Vol. 175 attempts to chromatograph this enzyme on Sepharose-C6-GlcN (Chesher et al., 1973) were unsuccessful, an observation confirmed by others (E. A. Barnard, personal communication). The K1 values for the C3-GlcN, C4-GlcN and C6-GlcN derivatives increased rapidly as the length of the spacer molecule was increased (Fig. 7a) . However, the addition of two methylene groups to the spacer molecule had a dramatic effect on the inhibitory properties of this glucosamine derivative (cf. Ki 24.2mM for C6-GlcN and Ki 0.9mM for C8-GlcN). It was therefore possible to chromatograph successfully a crude yeast extract on Sepharose-C8-GlcN (Fig. 7b ) and obtain a 20-25-fold purification. Although this is only shown on a small scale here, our experience with the mammalian hexokinases suggests that it is also possible to scale up this method.
Discussion
For the first time it has been shown possible to purify to homogeneity all four mammalian hexokinases by a combination of conventional and affinity techniques. The key to each purification was the use of a glucosamine affinity matrix in which a high degree of specificity for a particular hexokinase isoenzyme could be introduced by either varying the length of the spacer molecule and/or varying the ligand concentration coupled to the gel. In principle the method should be applicable to the purification of any hexokinase inhibited by N-acetylglucosamine. It was particularly noteworthy that the choices of matrix, ligand concentration and operating conditions were largely predicted from free solution kinetic data. These results explain our earlier puzzling observations that, when liver extracts were applied to Sepharose-C6-GlcN, only glucokinase was bound and low-Km hexokinase activity was unretarded (Chesher et al., 1973) . Under the conditions of these experiments, hexokinase type I, the major low-Km hexokinase in liver, would not be expected to bind to this affinity matrix. In this respect the report by Rijksen & Staal (1976) on the purification of human erythrocyte hexokinase type I is particularly noteworthy. These authors used an immobilized glucosamine derivative (Sepharose-C6-GlcN in our nomenclature) as the final step of their purification scheme. They showed that, although the enzyme did not bind very efficiently, it was sufficiently retarded to achieve the required purification. Although they did not report a ligand concentration attached to the gel, their mode of preparation suggests that it was at least 10,umol/g of gel, conditions where we observed a retardation (but not binding) of the rat kidney hexokinase type I. Our experience suggests that an immobilized C8-GlcN conjugate would provide a more efficient affinity matrix. There are considerable differences, however, between the two type I enzymes; the rat hexokinase is more active (specific activity of 180 units/mg at 30°C compared with 25-50 units/mg at 37°C for the human enzyme) and smaller (mol.wt. 96000 as opposed to 132000).
The exact nature of the interaction of enzyme with immobilized ligand is difficult to assess. Increasing the length of the spacer molecule, in general terms, increases the strength of binding of the enzymes to the matrices, but it would be naive to suggest an increased steric availability of the glucosamine as being responsible for this. Indeed, the fact that hexokinase type II will bind to the immobilized conjugates of all the N-aminoacylglucosamine derivatives tried and, in more general terms, the strong correlation between the kinetic and chromatographic data argue for an altogether more specific explanation. Nevertheless it was somewhat unexpected that the K1 values that such a closely related family of enzymes exhibit towards the N-aminoacylglucosamine derivatives should differ so markedly as the carbon chain length is increased. This must reflect differences in their active-site conformations, and it is probable that the binding of the ligands to the enzymes involves a combination of steric, hydrophobic and electrostatic interactions. In this respect it should be emphasized that the positively charged amino function of the N-aminoacylglucosamine derivatives under the conditions of the kinetic studies would be retained in the isQurea generated when these derivatives were coupled to CNBr-activated agarose (Wilchek, 1974) .
It did not escape our notice that in most cases where the Ki value was less than 2mM these values were obtained from mixed-inhibition systems (as opposed to purely competitive), although only the competitive component was used in the construction of Fig. 3 . Since this increased inhibition generally occurs with the longer polymethylene chains, it could be interpreted as an increased hydrophobic component in the enzyme-ligand interaction that may help to reinforce the affinity effects (Barry & O'Carra, 1973) . These affinity columns were always operated with a very high yield ofhexokinase, usually90-100 %. If the total yield of applied protein was calculated, however, it was always much less than this and varied with the purity of the applied sample. These effects have been noticed in our previous studies (Holroyde et al., 1976a,b) . In addition, the 'capacity' of the affinity columns for these enzymes also depended on the purity ofthe applied sample: the purer the sample, the higher the 'capacity'. This phenomenon can be expected in low-affinity systems where non-specific adsorption of protein can readily interfere with specific interactions. Thus the more impure the fraction to be chromatographed the larger the column required (see also Paulson et al., 1977; Schwyzer & Hill, 1977) . The low-affinity systems described here do have the one advantage that adjustment of ligand concentration can dramatically affect the subsequent chromatography. In very-highaffinity systems such an adjustment of ligand concentration is likely to run into steric/accessibility problems. It has been suggested that the important quantitative differences in the behaviour of the hexokinase isoenzymes towards these various affinity matrices reflect (slight) differences in their active-site conformations. By this criterion, the active site of the yeast enzyme appears to differ most from the others, a prediction borne out by affinity-labelling experiments with N-bromoacetylglucosamine (cf. Otieno et al., 1975 Otieno et al., , 1977 Connolly & Trayer, 1978) .
